Evidence map›Paper›PMID 33310486›Full record

ArticleDrug and alcohol dependence2021

Estimates of people who injected drugs within the last 12 months in Belgium based on a capture-recapture and multiplier method.

Els Plettinckx, Forrest W Crawford, Jérôme Antoine, Lies Gremeaux, Luk Van Baelen

Abstract read
In one paragraph

Article in Drug and alcohol dependence, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Dependence-Robust Confidence Intervals for Capture-Recapture Surveys.Journal of survey statistics and methodology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Els PlettinckxDirectorate of Epidemiology and Public Health, Sciensano, Rue Juliette Wytsmanstraat, 14, 1050 Brussels, Belgium. Electronic address: els.plettinckx@sciensano.be.
Forrest W CrawfordDepartment of Biostatistics, Yale School of Public Health, 60 College Street, New Haven, CT 06520-0834, United States.
Jérôme AntoineDirectorate of Epidemiology and Public Health, Sciensano, Rue Juliette Wytsmanstraat, 14, 1050 Brussels, Belgium.
Lies GremeauxDirectorate of Epidemiology and Public Health, Sciensano, Rue Juliette Wytsmanstraat, 14, 1050 Brussels, Belgium.
Luk Van BaelenDirectorate of Epidemiology and Public Health, Sciensano, Rue Juliette Wytsmanstraat, 14, 1050 Brussels, Belgium.

Funding

Network-based epidemiology for hidden and hard-to-reach populationsDP2HD091799 · NICHD · YALE UNIVERSITY · PI CRAWFORD, FORREST WRENN · 2016 to 2016
$2.5M
NICHD NIH HHS DP2 HD091799
6 · The paper itself

Abstract

backgroundFor Belgium, available estimates of the number of people who inject drugs (PWID) are based on data from more than fifteen years ago and apply only to those who report ever injecting drugs. As a result, no reliable baseline data exist to determine the scale of services for PWID.

methodsWe obtained pseudo-anonymized identifier information from treatment and harm reduction service providers and a fieldwork study between February and April 2019 in Brussels. We estimated the number of PWID, defined as people who injected within the last 12 months, in Brussels using capture-recapture (CRC) methodology. To obtain national estimates, we scaled the proportion of PWID in Brussels to the total number of this population in Belgium based on two existing drug treatment registers, which were then multiplied with the result of the CRC.

resultsThe total population of PWID is estimated to be 703 (95 %CI 538-935) for Brussels and between 6620 (95 %CI 4711 - 8576) and 7018 (95 %CI 4794 - 9527) for Belgium.

conclusionsThese estimates provide crucial information to ensure that services to PWID are adequately maintained. They clearly indicate the need to maximize efforts to achieve the targets set by WHO for 2030 on the provision of 300 sterile needles and syringes per PWID per year, a 90 % reduction of new HCV infections, and a 65 % reduction of liver-related mortality.

Indexed as

BelgiumFemaleHarm ReductionHumansMalePharmaceutical PreparationsSubstance Abuse, IntravenousSyringesWorld Health OrganizationPharmaceutical PreparationsCapture-recaptureHarm reductionHidden populationMultiplier methodPeople who inject drugsTreatment

Identifiers

PMID33310486
PMCPMC7856246

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.